| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.73B | 67.08B | 61.95B | 59.03B | 51.74B | 48.42B |
| Gross Profit | 30.65B | 30.20B | 27.62B | 26.30B | 22.88B | 21.64B |
| EBITDA | 10.97B | 10.61B | 9.73B | 9.27B | 7.22B | 6.18B |
| Net Income | 6.94B | 6.47B | 5.30B | 5.53B | 3.57B | 3.34B |
Balance Sheet | ||||||
| Total Assets | 68.24B | 69.00B | 71.99B | 69.42B | 59.24B | 54.33B |
| Cash, Cash Equivalents and Short-Term Investments | 12.85B | 13.35B | 14.64B | 15.00B | 11.88B | 13.12B |
| Total Debt | 13.17B | 13.58B | 17.84B | 21.82B | 19.37B | 19.23B |
| Total Liabilities | 24.96B | 26.20B | 34.22B | 36.84B | 32.19B | 30.94B |
| Stockholders Equity | 43.17B | 42.71B | 37.67B | 32.50B | 24.16B | 20.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.05B | 5.49B | 3.21B | -289.00M | 3.55B |
| Operating Cash Flow | 0.00 | 6.58B | 7.17B | 4.10B | 1.78B | 5.19B |
| Investing Cash Flow | 0.00 | -2.00B | -2.01B | -1.36B | -2.40B | -2.22B |
| Financing Cash Flow | 0.00 | -5.44B | -5.64B | 452.00M | -741.00M | -257.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥79.64B | 8.26 | ― | 2.31% | 6.50% | 30.54% | |
79 Outperform | ¥108.63B | 15.13 | ― | 3.23% | 7.28% | 4.16% | |
78 Outperform | ¥883.83B | 12.89 | 11.99% | 0.65% | 8.50% | 14.06% | |
78 Outperform | ¥320.90B | 8.42 | ― | 2.04% | -0.69% | -29.88% | |
75 Outperform | ¥1.12T | 19.48 | 11.14% | 1.46% | 3.92% | 9.99% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥919.59B | 36.79 | 2.99% | 2.62% | 3.51% | ― |